Avadel Pharmaceuticals Ltd (AVDL)

[Paullee]

https://finance.yahoo.com/news/top-cheap-stocks-week-130223440.html
Avadel Pharmaceuticals plc (NASDAQ:AVDL)

Avadel Pharmaceuticals PLC identifies, develops, and commercializes pharmaceutical products for primary care and sterile injectable markets in the United States, France, and Ireland. Founded in 1990, and headed by CEO Michael Anderson, the company size now stands at 179 people and with the company’s market capitalisation at USD $334.00M, we can put it in the small-cap stocks category.

AVDL’s stock is currently hovering at around -76% under its true value of $36.9, at a price of $8.68, based on its expected future cash flows. The difference between value and price signals a potential opportunity to buy AVDL shares at a discount. Moreover, AVDL’s PE ratio is currently around 4.4x relative to its pharmaceuticals peer level of 24.2x, implying that relative to its comparable company group, AVDL’s shares can be purchased for a lower price. AVDL is also in great financial shape, with near-term assets able to cover upcoming and long-term liabilities. AVDL also has a miniscule amount of debt on its balance sheet, which gives it headroom to grow and financial flexibility.
NasdaqGM:AVDL PE PEG Gauge Dec 17th 17
NasdaqGM:AVDL PE PEG Gauge Dec 17th 17